ASBP
Aspire Biopharma Holdings In
NASDAQ · Pharmaceuticals
$1.46
+0.14 (+10.61%)
Open$1.35
Previous Close$1.32
Day High$1.49
Day Low$1.26
52W High$25.10
52W Low$14.87
Volume—
Avg Volume578.8K
Market Cap5.05M
P/E Ratio16.64
EPS$1.29
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.20M | 2.09M | 2.38M |
| Net Income | 266.8K | 312.0K | 325.1K |
| Profit Margin | 12.1% | 14.9% | 13.7% |
| EBITDA | 501.0K | 520.7K | 532.7K |
| Free Cash Flow | 197.3K | 259.9K | 336.6K |
| Rev Growth | +5.7% | +22.2% | +15.1% |
| Debt/Equity | 0.42 | 0.41 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |